Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Clarivate Analytics

- PMLiVE

Clinigen launches ‘What is Possible?’ campaign on Rare Disease Day to accelerate access to medicines

There are over 7,000 rare diseases impacting more than 300 million people globally

- PMLiVE

Global donors pledge over $777m to fight neglected tropical diseases at COP28 summit

The $500m Reaching the Last Mile Fund will reach an additional 32 countries

- PMLiVE

Bill & Melinda Gates Foundation commit $1.2bn as part of efforts to end polio worldwide

The pledge will aid the implementation of the GPEI’s Polio Eradication Strategy 2022-2026

dengue fever mosquito

Manus Bio awarded $2m by Bill & Melinda Gates Foundation to combat malaria

The additional funding will accelerate the development of a production route for artemisinin, a key therapeutic for treating malaria

- PMLiVE

Pandemic Antiviral Discovery initiative created by the Novo Nordisk Foundation, Open Philanthropy and the Gates Foundation

The initiative, backed with funding of up to $90m, will aid in the discovery and development of antiviral drug candidates

EU cross-border healthcare

The clock is ticking to improve access to gene and cell therapies for rare diseases

- PMLiVE

Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy

Project will aim to discover and develop a gene therapy for sickle cell disease

- PMLiVE

Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund

Partners commit $125m to seed-fund for potential treatments

- PMLiVE

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

Grant will help accelerate medicine registration in low/middle-income countries

- PMLiVE

The changing nature of approvals – what does the future hold?

The 2019 CMR International Pharmaceutical R&D Factbook

- PMLiVE

NICE International relaunches, will offer advisory services

Meets growing demand from global health and social care organisations

- PMLiVE

NIH, Gates pledge $200m for HIV and sickle cell gene therapies

Aim to bring therapies to patients in lower-income countries

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links